Faster access than browser!
15 relations: Amicus Therapeutics, Eliglustat, European Medicines Agency, Food and Drug Administration, Gaucher's disease, Glucocerebroside, Imiglucerase, Iminosugar, International nonproprietary name, Miglustat, Mikael Bols, Orphan drug, Protein structure, Shire (pharmaceutical company), Tartrate.
Amicus Therapeutics
Amicus Therapeutics is a public American biopharmaceutical company based in Cranbury, New Jersey.
New!!: Afegostat and Amicus Therapeutics · See more »
Eliglustat
Eliglustat (INN, USAN; trade name Cerdelga) is a treatment for Gaucher's disease developed by Genzyme Corp that was approved by the FDA August 2014.
New!!: Afegostat and Eliglustat · See more »
European Medicines Agency
The European Medicines Agency (EMA) is a European Union agency for the evaluation of medicinal products.
New!!: Afegostat and European Medicines Agency · See more »
Food and Drug Administration
The Food and Drug Administration (FDA or USFDA) is a federal agency of the United States Department of Health and Human Services, one of the United States federal executive departments.
New!!: Afegostat and Food and Drug Administration · See more »
Gaucher's disease
Gaucher's disease or Gaucher disease (GD) is a genetic disorder in which glucocerebroside (a sphingolipid, also known as glucosylceramide) accumulates in cells and certain organs.
New!!: Afegostat and Gaucher's disease · See more »
Glucocerebroside
Glucocerebroside (also called glucosylceramide) is any of the cerebrosides in which the monosaccharide head group is glucose.
New!!: Afegostat and Glucocerebroside · See more »
Imiglucerase
Imiglucerase is a medication used in the treatment of Gaucher's disease.
New!!: Afegostat and Imiglucerase · See more »
Iminosugar
An iminosugar, also known as an iminosaccharide, is any analog of a sugar where a nitrogen atom has replaced the oxygen atom in the ring of the structure.
New!!: Afegostat and Iminosugar · See more »
International nonproprietary name
The International Nonproprietary Name (INN) is an official generic and non-proprietary name given to a pharmaceutical drug or an active ingredient.
New!!: Afegostat and International nonproprietary name · See more »
Miglustat
Miglustat (OGT 918, N-butyl-deoxynojirimycin) is a drug developed by Oxford GlycoSciences and marketed by Actelion and is used primarily to treat type I Gaucher disease (GD1).
New!!: Afegostat and Miglustat · See more »
Mikael Bols
Mikael Bols (born July 28, 1961) is a synthetic organic chemist who is mainly known for his work on carbohydrates and artificial enzymes.
New!!: Afegostat and Mikael Bols · See more »
Orphan drug
An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease.
New!!: Afegostat and Orphan drug · See more »
Protein structure
Protein structure is the three-dimensional arrangement of atoms in an amino acid-chain molecule.
New!!: Afegostat and Protein structure · See more »
Shire (pharmaceutical company)
Shire Plc is a Jersey-registered, Irish-headquartered global specialty biopharmaceutical company.
New!!: Afegostat and Shire (pharmaceutical company) · See more »
Tartrate
A tartrate is a salt or ester of the organic compound tartaric acid, a dicarboxylic acid.
New!!: Afegostat and Tartrate · See more »
Redirects here:
Isofagomine, Isofagomine tartrate, Plicera.
